- Home
- PRTC vs CDRO Comparison
PRTC vs CDRO Comparison
Compare PRTC & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- CDRO
- Stock Information
- Founded
- PRTC 2015
- CDRO 2014
- Country
- PRTC United States
- CDRO Luxembourg
- Employees
- PRTC N/A
- CDRO N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- CDRO Services-Misc. Amusement & Recreation
- Sector
- PRTC Health Care
- CDRO Consumer Discretionary
- Exchange
- PRTC Nasdaq
- CDRO Nasdaq
- Market Cap
- PRTC 413.5M
- CDRO 381.1M
- IPO Year
- PRTC N/A
- CDRO N/A
- Fundamental
- Price
- PRTC $19.07
- CDRO $8.45
- Analyst Decision
- PRTC Buy
- CDRO Strong Buy
- Analyst Count
- PRTC 1
- CDRO 1
- Target Price
- PRTC $45.00
- CDRO $10.00
- AVG Volume (30 Days)
- PRTC 3.4K
- CDRO 41.5K
- Earning Date
- PRTC 08-27-2025
- CDRO 07-31-2025
- Dividend Yield
- PRTC N/A
- CDRO N/A
- EPS Growth
- PRTC N/A
- CDRO N/A
- EPS
- PRTC 0.21
- CDRO 0.08
- Revenue
- PRTC $4,828,000.00
- CDRO $207,789,626.00
- Revenue This Year
- PRTC $35.98
- CDRO $13.97
- Revenue Next Year
- PRTC $115.38
- CDRO $8.37
- P/E Ratio
- PRTC $8.64
- CDRO $102.02
- Revenue Growth
- PRTC 44.98
- CDRO 24.16
- 52 Week Low
- PRTC $13.30
- CDRO $5.75
- 52 Week High
- PRTC $25.00
- CDRO $8.76
- Technical
- Relative Strength Index (RSI)
- PRTC 57.26
- CDRO 61.16
- Support Level
- PRTC $18.16
- CDRO $8.22
- Resistance Level
- PRTC $19.60
- CDRO $8.75
- Average True Range (ATR)
- PRTC 0.43
- CDRO 0.31
- MACD
- PRTC 0.10
- CDRO -0.02
- Stochastic Oscillator
- PRTC 69.77
- CDRO 60.00
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.